| Major lipids, apolipoproteins, and risk of vascular disease R Assessment Jama 302 (18), 1993-2000, 2009 | 3135 | 2009 |
| Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women BG Nordestgaard, M Benn, P Schnohr, A Tybjærg-Hansen Jama 298 (3), 299-308, 2007 | 2555 | 2007 |
| Remnant cholesterol as a causal risk factor for ischemic heart disease A Varbo, M Benn, A Tybjærg-Hansen, AB Jørgensen, R Frikke-Schmidt, ... Journal of the American College of Cardiology 61 (4), 427-436, 2013 | 1118 | 2013 |
| Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication M Benn, GF Watts, A Tybjaerg-Hansen, BG Nordestgaard The Journal of Clinical Endocrinology & Metabolism 97 (11), 3956-3964, 2012 | 798 | 2012 |
| Rare and low-frequency coding variants alter human adult height E Marouli, M Graff, C Medina-Gomez, KS Lo, AR Wood, TR Kjaer, RS Fine, ... Nature 542 (7640), 186-190, 2017 | 669 | 2017 |
| Extreme lipoprotein (a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study PR Kamstrup, M Benn, A Tybjærg-Hansen, BG Nordestgaard Circulation 117 (2), 176-184, 2008 | 632 | 2008 |
| Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies M Traylor, M Farrall, EG Holliday, C Sudlow, JC Hopewell, YC Cheng, ... The Lancet Neurology 11 (11), 951-962, 2012 | 591 | 2012 |
| Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease … A Varbo, M Benn, A Tybjærg-Hansen, BG Nordestgaard Circulation 128 (12), 1298-1309, 2013 | 555 | 2013 |
| Exome-wide association study of plasma lipids in> 300,000 individuals DJ Liu, GM Peloso, H Yu, AS Butterworth, X Wang, A Mahajan, ... Nature genetics 49 (12), 1758-1766, 2017 | 554 | 2017 |
| Association of LPA variants with risk of coronary disease and the implications for lipoprotein (a)-lowering therapies: a Mendelian randomization analysis S Burgess, BA Ference, JR Staley, DF Freitag, AM Mason, SF Nielsen, ... JAMA cardiology 3 (7), 619-627, 2018 | 503 | 2018 |
| Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217 M Benn, GF Watts, A Tybjærg-Hansen, BG Nordestgaard European heart journal 37 (17), 1384-1394, 2016 | 428 | 2016 |
| PCSK9R46L, Low-Density Lipoprotein Cholesterol Levels, and Risk of Ischemic Heart Disease: 3 Independent Studies and Meta-Analyses M Benn, BG Nordestgaard, P Grande, P Schnohr, A Tybjærg-Hansen Journal of the American College of Cardiology 55 (25), 2833-2842, 2010 | 384 | 2010 |
| Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity V Turcot, Y Lu, HM Highland, C Schurmann, AE Justice, RS Fine, ... Nature genetics 50 (1), 26-41, 2018 | 354 | 2018 |
| The effect of elevated body mass index on ischemic heart disease risk: causal estimates from a Mendelian randomisation approach BG Nordestgaard, TM Palmer, M Benn, J Zacho, A Tybjaerg-Hansen, ... PLoS medicine 9 (5), e1001212, 2012 | 341 | 2012 |
| 25-hydroxyvitamin d levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies P Brøndum-Jacobsen, M Benn, GB Jensen, BG Nordestgaard Arteriosclerosis, thrombosis, and vascular biology 32 (11), 2794-2802, 2012 | 336 | 2012 |
| Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts TM Palmer, BG Nordestgaard, M Benn, A Tybjærg-Hansen, GD Smith, ... Bmj 347, 2013 | 317 | 2013 |
| High lipoprotein (a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study A Langsted, PR Kamstrup, M Benn, A Tybjærg-Hansen, BG Nordestgaard The lancet Diabetes & endocrinology 4 (7), 577-587, 2016 | 288 | 2016 |
| 25‐hydroxyvitamin D and symptomatic ischemic stroke: an original study and meta‐analysis P Brøndum‐Jacobsen, BG Nordestgaard, P Schnohr, M Benn Annals of neurology 73 (1), 38-47, 2013 | 280 | 2013 |
| Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease W Zhao, A Rasheed, E Tikkanen, JJ Lee, AS Butterworth, JMM Howson, ... Nature genetics 49 (10), 1450-1457, 2017 | 266 | 2017 |
| Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment A Varbo, M Benn, BG Nordestgaard Pharmacology & therapeutics 141 (3), 358-367, 2014 | 260 | 2014 |
